The innovation and clinical application of ischemia-free organ transplantation
Visualized Cancer Medicine · 2021
DOI: 10.1051/vcm/2021005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Visualized Cancer Medicine, 2021. Verfasst von Zhiyong Guo und 3 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The incidence rate of liver cancer is increasing year by year globally. Liver transplantation has become one of the therapeutic methods for patients with liver cancer. In the past, ischemia-reperfusion injury (IRI) was unavoidable in liver transplantation, compromising recipient and graft survival. At the same time, the imbalance between the supply and demand of organs limits the use of transplantation in patients with liver cancer. Recently, advances have been made in machine perfusion techniques to reduce graft IRI. However, none of the techniques can completely abrogate graft IRI. In 2017, the concept of ischemia-free organ transplantation (IFOT) was proposed, and our group conducted the first case of ischemia-free liver transplantation (IFLT). We then extended the concept of IFOT to kidney transplantation in 2018 and to heart transplantation in 2021. Here, we review the history, strengths, and weaknesses, and the future direction of IFOT, particularly in patients with liver cancers.
Zitieren
APA
Guo, Z., Luo, T., Zhao, Q., & He, X. (2021). The innovation and clinical application of ischemia-free organ transplantation. Visualized Cancer Medicine. https://doi.org/10.1051/vcm/2021005
Vancouver
Guo Z, Luo T, Zhao Q, He X. The innovation and clinical application of ischemia-free organ transplantation. Visualized Cancer Medicine. 2021. doi:10.1051/vcm/2021005
BibTeX
@article{Guo2021,
author = {Guo, Zhiyong and Luo, Tao and Zhao, Qiang and He, Xiaoshun},
title = {The innovation and clinical application of ischemia-free organ transplantation},
journal = {Visualized Cancer Medicine},
year = {2021},
doi = {10.1051/vcm/2021005}
}
EUVIMED